Orphenadrine
- Level
- Commodity
- Parent
- 51152000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51152041This classification denotes a muscle relaxant and antimuscarinic agent with the molecular formula C18H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AL805O9OG9, chemically known as n,n-dimethyl-2-(o-methyl-.alpha.-phenylbenzyloxy)ethylamine hydrochloride but generally known as orphenadrine, which bears US NIH Compound Identifier 4601. European Medicines Agency schedules Orphenadrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09471MIG. ORPHENADRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule orphenadrine under HS 29221980 and SITC 51461. As of Q4 2014, ORPHENADRINE remains the US FDA Preferred Term for this commodity. Orphenadrine bears US NLM identifiers UMLS ID C0029309 and NCI Concept Code C61868. SMILES: O(C(C1C(CCCC1)C)C1CCCCC1)CCN(C)C.
Same parent
Under 51152000 · 74Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.